Eden Research Share Discussion Threads

[investingisatrickygame] 04/8/2018 13:53

I get that and I don't disagree with your theory. Head lice and deodorant due. They could merely find a well placed distributor to go worldwide.

Personally,I think Sipcam and co-encapsulation has greater potential to re-rate the company and engage Bayer.

[supersonico] 04/8/2018 13:42

Investing,

Take one part of that big If.

Look at TT



What do they mean by 'World Wide'?

and how did they get World wide approval on the cash they have ?

I don't know about these things but my understanding is it's expensive and TT don't appear to have the means to achieve commercialisation for the 12 plus products unless that is they are doing it in a piece meal fashion but that's inefficient and contradicts Eden's effort to extend patent life and optimise profits, Does it not?. Overall it would be far more profitable would it not for TT to either Borrow a load of cash or have Bayer do it?

[investingisatrickygame] 04/8/2018 13:27

That's a big if

[supersonico] 04/8/2018 11:08

Investing,

Under a super secret NDA they have to be lofty and Incongruent.

You can wish all you like for a Holistic approach but if they've got Bayer's boot on their jugular that's not going to happen.. their hands are tied.

[investingisatrickygame] 04/8/2018 10:44

Super,

We'll see.

I just wish Eden would be a bit more holistic in their approach. Shareholders are part of the 'whole'.

I don't know a shareholder that is not totally frustrated with the Eden approach, even if they believe in there being an end result for shareholders.

As I posted on LSE, Eden needs to illustrate the size of the prize. That will certainly help the share price to move in the right direction.

[supersonico] 04/8/2018 10:12

In the absence of ShortorderRNS I give you some of the detail I expect in the not so shortorder SuperRNS

File under fantasy/conspiracy/fun .

In 2013/14 Bayer realised the potential of EDEN IP.

Sean Smith IP expert joins Eden.

Extension of TerpeneTech licence agreement June 2014

TT and EDEN signed a secret/ strict NDA and partnership agreement with Bayer.

The Incongruence starts here.

Bayer agreed to develop and commercialise all TT products plus some of their own using Eden IP for world wide sale while Eden would strengthen and maximise Eden IP under the watchful eye of IP expert Sean Smith.

Further extension of licence agreement and Eden bought 29.9% stake in TT Aug 2015.

Collaboration and Licence Agreement Signed with Intellectual Ventures Sept 2015

Inflexion point. Bayer Time Now 2017

Lykele van der Broek joins Eden as Bayer gets closer to worldwide rollout of all TT products developed over last 5 years to support Eden and help develop the team further as commercialisation and anticipated greater demands on current team approaches


'I am confident that Eden's prospects are bright, and we remain focussed on a programme of prudent financial management coupled with well-informed decision making and timely execution. Over the past few years it has been reported that the Company has "shifted gears", and this is an apt metaphor. Continuing this theme, I am looking forward to building speed and positioning Eden to be amongst the leaders in our industry'. Sean Smith preliminary Results

[supersonico] 04/8/2018 06:28

Investing,

So hard to tell, but I'd be making sure the undamaged part of my harvest was well protected. Sumiagro look like they have been more active in the PR department this year and word of mouth amongst growers has had longer to bed in so I still expect sales in France to be 200-300% higher than 2017 despite the poor conditions.

Remember we are starting from a very low base and Sean Smith did say it has been very well received by growers.

[bjlk] 04/8/2018 06:21

InvestingMy thoughts exactly....a very erudite conclusion to a very patronising and out of touch email....FRUSTRATING!! Arrrrrrgh

[investingisatrickygame] 03/8/2018 22:22

Super,

As Eden doesn't yet treat or help to prevent Mildew, that means there will be less remaining harvest that can be affected in due course by Botrytis and therefore addressed by Mevalone. So I assume that although Eden will have made sales to Sumi-Agro and they too may have sold to farmers already, in the field application in Bordeaux could be relatively minimal or lower than hoped for this season.

Is this how you read this situation for Bordeaux in regards to Mevalone?

[investingisatrickygame] 03/8/2018 16:57

Bjik

From your email

"Share price movement is not one of the targets of bonuses due to the short-term nature of annual bonus payments. Rather, the executive team is incentivised on a longer term basis via a long term incentive programme where our interests are tied directly to those of shareholders and where our actions should support longer term share price appreciation."

That is a very interesting statement. Most people investing would not consider, in my opinion, 12 months short-term and in the long-term, everyone is not going to sit around hoping for an Apple inc return of 50,000-1.

Share price appreciation should be progressive and that includes the short-term of 12 months. Had those invested known that there is no real incentive to invest for the next 12 months (whatever historical 12 month period that was), then I imagine they would have gone elsewhere and not left dead money in Eden, preferring to review Eden in a years time.

The long-term incentive plan aligns the executives with the executives! It may well align the executives with some shareholders, but most definitely not all or I doubt, the majority.

It is not unreasonable for all shareholders to expect a return on their investment within the year, albeit, not as large as longer term investors who hopefully reap the rewards of greater commercial success. To acknowledge the fact that there will be little or no return within a year merely encourages investors to look elsewhere on AIM or other markets and seek out companies who both want their investors hard earned monies and offer a good shot at a decent return.

Eden for me, doesn't get the private investor, their motivations, their needs, their wants, the reasons why they invested. Eden doesn't work in tandem with those shareholders to deliver the same. Executives motivations for their shareholding when they work in the Company, are handsomely rewarded and can wait 5 years for a return. These are misaligned with the average AIM investor.

Eden should ask themselves "there are 1,000 companies on AIM. What makes an investment in our company more compelling than putting your money elsewhere". When they answer that question fully, they will understand why theirs and our share price is stuck @ circa 12pence and going nowhere.

Investor pounds need to be fought for, earned and respected in order to retain and build your investment community and share price. If you don't, your share price is always at the negative mercy of 'dead money'!

[bjlk] 03/8/2018 15:20

Dear bjlk, Thank you for your e-mails. Please let me attempt to address the matters you have highlighted.Firstly, Eden's remuneration policy is managed and implemented by its remuneration committee - which is exclusively made up of our independent, non-executive directors. They have recently completed a benchmarking study (with the aid of a well-known recruitment agency), and reached the conclusion that our remuneration policy is in-line with that of our peers. This has taken into consideration our stage of development (pre-commercial versus commercial - using our "pre-commercial" peers as the benchmark). Whilst your view seems to be our remuneration is excessive, I can only say that it is actually in line (or slightly behind) that of our peers. You will understand the need to offer competitive remuneration packages capable of attracting and retaining suitable employees. Remuneration is under ongoing review, and our policy is to remain competitive with our peers and in-line with the stage of our development. Bonuses are paid based upon the achievement of clearly defined and measurable milestones. Share price movement is not one of the targets of bonuses due to the short-term nature of annual bonus payments. Rather, the executive team is incentivised on a longer term basis via a long term incentive programme where our interests are tied directly to those of shareholders and where our actions should support longer term share price appreciation. Our bonus and incentive programmes are benchmarked and reflect current best-practice, and bonus payments are made only on the condition that the company has an adequate funded runway.Regarding Twitter... we are happy to un-block you, but please be advised that Eden does not maintain and operate a Twitter account in order to provide shareholders (or anyone else) with an opportunity to publicly criticise the Company. Should you wish to follow our developments via Twitter, we are pleased to welcome you back. However, to be clear, we will block your account again should you again post negative or critical comments. I appreciate that you may consider this to be unfair, but there are numerous alternative vehicles through which you can communicate your criticisms publicly, including multiple bulletin boards and even e-mail, if you wish to speak directly to us.I hope that helps address your concerns. Though we cannot commit to always respond to shareholder enquiries, we will endeavour to do so whenever possible, and we welcome your comments.Many thanks and best regards,Sean________________________________________________________________________Sean SmithChief Executive OfficerEden Research plc6 Priory CourtPriory Court Business ParkPoultonCirencesterGL7 5JB

[supersonico] 03/8/2018 13:32

Like I keep saying Bjlk

Lofty and Incongruent.

[bjlk] 03/8/2018 12:57

On the management being 'with us or against us' -they blocked me from their twitter site due to some genuine tweets asking for news etc possibly a bit sarcastically but in the main just a frustrated investor begging for any crumb of news etcI am now able to tweet on the understanding that negative tweets are not welcome due to there being other forums where that can go on!!!! Like being in with the headteacher!!! It might be because there is so little on their twitter page 1 questioning tweet could ruin things.....Anyway just really frustrated in the deathly silence but hey this is the right forum to do it on!!!!

[investingisatrickygame] 03/8/2018 08:31

"the rewards will last for longer."

For those able to stay invested.

I agree with bjik

[attyg] 03/8/2018 07:26

Yes, these delays test the patience of a saint and we know not many saints "invest" in the stock market. Consequently, not much buying interest.
I remain a wholehearted supporter.
Our rewards will come and they should be big.
Sadly, and it seems like forever, we have to sit on our hands.
I remain of the view that the company will change for the good before 31 Dec 2018.
By then, we must surely have TT launching head lice, Bayer launching dog deodorants, (both could well have advanced other commercial products as well); Sipcam paying up for options before 31 Dec, some significant ones we know that are up for grabs include USA and China; plus co-encapsulation - this could/should include Sipcam, Bayer and Eastman? Plus further news on Cedroz commercialisation.
We will also have updated position regarding 3AEY sales,developments on powdery mildew etc etc.
There is a lot happening - we are a tiny minnow, we are dealing with large to giant global companies, we have good agreements in place supported by well defended IP.
While it is taking longer than I would wish, the rewards will last for longer.

[supersonico] 02/8/2018 22:36

We can only hope it's a Bayer NDA..I suspect it is..which will hopefully be good in the long run for shareholders if they manage to survive the excruciating short order Lykele..haha Poulton Nederlandse humor wait.

[bjlk] 02/8/2018 22:11

I for one am utterly bewildered in the muteness of the management in communicating anything, in short order -ha ha ... this has been going on for years - it's a confidentiality agreement , we cannot tell you anything.. Bla bla bla can't give you any numbers , time frame or anything other than jam tomorrow and believe us....Where is the communication , updates on sales figures, projections etc etc , PR, visibilityAre they all on holiday again??

[supersonico] 31/7/2018 13:33

Northwick;

'And a few that I know are unwilling to express their frustrations and disappointment openly to the Management in the fear they maybe left out in the cold'.

Are you saying Eden disapprove of descent in the ranks and deal with it by excommunication ? I always thought they'd deal with far more severely and ration the Werther's Originals.

[northwick] 31/7/2018 13:03

Reasons for holding shares in Eden are, for me at least, diminishing by the day and am not sure how long to wait.Eminent journalists have said that it is a waiting game for Eden but aren't willing to say how long. Long term investors are also worried about return of their capital let alone a profit on their investment. And a few that I know are unwilling to express their frustrations and disappointment openly to the Management in the fear they maybe left out in the cold.Management has again reneged with in not communicating well with its shareholders. It hasn't even informed the market of the delays TT has suffered in obtaining regulatory clearance of its head lice ( and maybe others) products, which according to their own Published accounts were due by end of June.I now don't BLAME Shore capital in not believing in what management says to them. This is the third time Management have failed to execute their own plans.Time is ebbing away for all of us

[investingisatrickygame] 31/7/2018 12:18

No one seems to care about the share price. No one seems to align with or understand shareholders. The gap between the two is huge.

It is fine that 'one day', but that approach turns shareholders off and in part, accounts for where the share price is today.

If Eden is not 50p before Christmas on the back of the to be announced Bayer, TT, Mevalone US, Sipcam + anything else, then maybe that raises questions about investment return v time here.

Thus far and allowing for commercial progress, the share price has not traded up at all. There are reasons for that.

[supersonico] 31/7/2018 10:59

Investing,

Expecting Eden to deliver on time is like expecting Fraudy to take Eden off his (hidden to avoid the blushes) Sell list when we are at 50p.

Leopards, Spots and Team sports mentality.

The Only certainty is incongruence.

[investingisatrickygame] 30/7/2018 16:39

Boredom with Eden and its never changing share price has clearly set in.

What a shame that is!